4.7 Review

The Gut-Brain Axis in Schizophrenia: The Implications of the Gut Microbiome and SCFA Production

Journal

NUTRIENTS
Volume 15, Issue 20, Pages -

Publisher

MDPI
DOI: 10.3390/nu15204391

Keywords

schizophrenia; gut microbiota; gut-brain axis; blood-brain barrier; short-chain fatty acids

Ask authors/readers for more resources

Schizophrenia, a severe mental illness affecting about 1% of the population, is influenced by multiple factors including genetics, adversity, infection, and gene-environment interactions. Recent research suggests that maternal infection or stress during pregnancy may increase the risk of schizophrenia in offspring. The gut-brain axis, specifically the gut microbiome, has been found to play a significant role in CNS function and mental health, including schizophrenia.
Schizophrenia, a severe mental illness affecting about 1% of the population, manifests during young adulthood, leading to abnormal mental function and behavior. Its multifactorial etiology involves genetic factors, experiences of adversity, infection, and gene-environment interactions. Emerging research indicates that maternal infection or stress during pregnancy may also increase schizophrenia risk in offspring. Recent research on the gut-brain axis highlights the gut microbiome's potential influence on central nervous system (CNS) function and mental health, including schizophrenia. The gut microbiota, located in the digestive system, has a significant role to play in human physiology, affecting immune system development, vitamin synthesis, and protection against pathogenic bacteria. Disruptions to the gut microbiota, caused by diet, medication use, environmental pollutants, and stress, may lead to imbalances with far-reaching effects on CNS function and mental health. Of interest are short-chain fatty acids (SCFAs), metabolic byproducts produced by gut microbes during fermentation. SCFAs can cross the blood-brain barrier, influencing CNS activity, including microglia and cytokine modulation. The dysregulation of neurotransmitters produced by gut microbes may contribute to CNS disorders, including schizophrenia. This review explores the potential relationship between SCFAs, the gut microbiome, and schizophrenia. Our aim is to deepen the understanding of the gut-brain axis in schizophrenia and to elucidate its implications for future research and therapeutic approaches.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available